L-Rhamnulose
| Product Name | L-Rhamnulose |
|---|---|
| Alternate Names | - Carbohydrates, Carbohydrates of - |
| CAT No. | CS-BX-01155 |
| CAS No. | 14807-05-7 |
| Category | Carbohydrates |
| Stock | Enquire |
| Mol. Wt. | 164.16 g/mol |
| Mol. For. | C6H12O5 |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | - |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Get an Instant Quote
Related Compounds
iGB5Cer d18:1/18:0-Biotin (Galb1,3GalNAcb1,3Gala1,3Galb1,4GlcbCeramide-Biotin) | Sakuranin | GM1aCer d18:1/16:0 (Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GT2Cer d20:1/16:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | Lewis A (Lea ) pentasaccharide | GD1aCer d18:1/12:0 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | Blood type trisaccharide H Type III/IV | GM2 | GD2Cer d18:1/16:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GT3Cer d20:1/16:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GloboHCer d18:1/18:0-Biotin ((Fuca1,2)Galb1,3GalNAcb1,3Gala1,4Galb1,4GlcbCeramide-Biotin) | FucGM1Cer d18:1/16:0 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GM1bCer d18:1/8:0 (Neu5Aca2,3Galb1,3GalNAcb1,4Galb1,4GlcbCeramide) | GM3Cer d20:1/16:0 (Neu5Aca2,3Galb1,4GlcbCeramide) | BLewis Y (ALe Y) | GM2Cer d18:1/18:0 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GT3Cer d20:1/20:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | Blood type trisaccharide H Type II | GM2Cer d18:1/8:0 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | C24:1 β-Glucosylceramide | Pk(Gala1,4Galb1,4GlcbR) | GQ3Cer d20:1/20:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | Gb5 | GM3Cer d20:1/20:0 (Neu5Aca2,3Galb1,4GlcbCeramide) | Lc3 | GD3Cer d20:1/24:1 (Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GM2sph d18:1 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbSphingolipids) | iGB3Cer d18:1/18:0-Biotin (Gala1,3Galb1,4GlcbCeramide-Biotin) | SSEA-4 | P(Galb1,3Gala1,4Galb1,4GlcbR) | GT1csph d20:1 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbSphingolipids) | GM2sph d20:1 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbSphingolipids) | GD3Cer d20:1/20:0 (Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | FucGM1Cer d18:1/8:0 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GD1aCer d20:1/12:0 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | FucGM1Cer d20:1/8:0 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | Gala1, 4Galb1, 4Glc | GD3Cer d18:1/24:1 (Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | Lactose PEG-NH2 | LacNAc PEG-NH2 | GT2 | GQ3Cer d20:1/16:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GM1bCer d18:1/20:0 (Neu5Aca2,3Galb1,3GalNAcb1,4Galb1,4GlcbCeramide) | FucGM1sph d18:1 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbSphingolipids) | GT3Cer d20:1/18:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GD1bCer d18:1/24:1 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GB4Cer d18:1/18:0-Biotin (GalNAcb1,3Gala1,4Galb1,4GlcbCeramide-Biotin) | GD1asph d20:1 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbSphingolipids) | GM1aCer d20:1/16:0 (Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | A-Antigen-Cer d18:1/18:0-Biotin (GalNAca1,3(Fuca1,2)Galb1,4GlcbCeramide-Biotin) | LewisaCer d20:1/24:1-Biotin (Galb1,3(Fuca1,4)GlcNAcb1,3Galb1,4GlcbCeramide-Biotin) | LNnDFH II | Sialyl-iGb5 | GD3Cer d20:1/18:0 (Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | FucGM1Cer d18:1/18:0-Biotin ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide-Biotin) | GM2Cer d18:1/24:1 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GT2Cer d18:1/12:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GT1cCer d20:1/24:1 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GD1aCer d20:1/16:0 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GT3Cer d18:1/18:0-Biotin (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide-Biotin) | GM2Cer d18:1/20:0 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | Neoglucobrassicin | GD1bCer d20:1/16:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GD2Cer d20:1/20:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GD3Cer d18:1/18:0-Biotin (Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide-Biotin) | ALewis B (ALe b ) | GQ3Cer d18:1/16:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GT2Cer d18:1/18:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GT3Cer d18:1/20:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GalNAcb1, 4Galb1, 4GlcNAc |